Search Results 2011-2020 of 17631 for rheumatoid arthritis
The aim is to compare outcomes in patients who receive acute normovolemic hemodilution (ANH) blood to control patients with post-CPB factor mediated ...
SSc classification as defined by the 2013 American College of Rheumatology/European League Against Rheumatism criteria. An enrollment cap will apply to the ...
Patients must fulfill the 2013 American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR) classification criteria for ...
The purpose of this study is to determine the effect of triple combination therapy with an anti-integrin (vedolizumab intravenous [IV]), a tumor necrosis factor ...
... arthritis, Median neuropathy, Cubital tunnel syndrome, Hand arthritis, Neuralgic amyotrophy, Nerve entrapment, Hand injury, Mononeuropathies, Inclusion body ...
Histone modifications CUT&Tag; ATAC-seq; Transcription factor CUT&RUN; RNA-seq; Integrative bioinformatic analyses. Dr. Wang is working with Mayo Clinic ...
Glaucoma is the leading cause of irreversible blindness in the United States and worldwide. Elevated eye pressure is the leading risk factor for glaucoma and ...
ROCHESTER, Minn. — Mayo Clinic researchers have found that a new, shorter treatment for patients with HPV-associated oropharynx cancer leads to excellent ...
Not everyone has been easily convinced. When he submitted one of his first federal grants to pursue gene therapy for arthritis, one of the reviews scoffed at ...
Stephen J. Wisniewski, M.D.. Sports Medicine Specialist; Physiatrist. Rochester, MN. Areas of focus: Sport specific rehabilitation, Arthritis rehabilitation, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your Annual Fund gift can drive advancements in cancer care.